Delivery Order SPE2DB22D2206-SPE2DB24FFK37
Award Date 2/1/24
Potential Completion Date 2/2/24
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, to provide TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccines. The $22,963.96 order has a completion date of February 28, 2024 and was awarded on February 27, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company that serves as a prime contractor for various DLA medical supply and...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $46,815.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccines. The contract has a completion date of March 7, 2024 and was awarded on March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded by...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccines. The contract has a ceiling value of $3,421.00 and a performance period through March 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds as the sole prime...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML pharmaceuticals. The $10,299.41 contract has a performance period through February 6, 2024 and is not designated as a set-aside. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor on this award, which is placed against a...
- The U.S. Defense Logistics Agency (DLA) awarded a $37,452.40 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 25 mcg/0.5 ml vials of the TYPHIM VI vaccine. This delivery order contract has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of up to $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML pharmaceuticals. The contract has a completion date of February 5, 2024 and a potential value of $3,586.12. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which was not set aside for any particular business type. This order is part...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,732.82 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with completion scheduled for December 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is fulfilling this...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $10,263.00 order is for the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine, to be delivered by February 5, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide this pharmaceutical product to support military treatment programs and facilities. This delivery order...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $3,471.49 contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccines to support military treatment programs and facilities. The contract has a completion date of February 1, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,029,675 units of the Typhim VI 25 mcg/0.5 mL vaccine vial in 10 mL sizes. The contract, valued at $74,946.36, has a period of performance through March 21, 2024. Amerisourcebergen Drug Corp is an established prime contractor for DLA, holding an indefinite delivery contract valued up to $999,999,999.00 through...